Adverse long-term effect of corticosteroid therapy in recent-onset sarcoidosis

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 20, Issue 3, 2003, Pages 227-234

  Reich, Jerome M ^a  

^a NONE   (United States)

Author keywords

Corticosteroids; Drug therapy; Sarcoidosis

Indexed keywords

BUDESONIDE; CORTICOSTEROID; CYCLOSPORIN A; METHYLPREDNISOLONE; PLACEBO; PREDNISONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE COURSE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; EVIDENCE BASED MEDICINE; HUMAN; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MEDLINE; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ADULT; CONTROLLED CLINICAL TRIALS; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; HUMANS; MORTALITY; RISK FACTORS; SARCOIDOSIS, PULMONARY;

EID: 0242331674     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. th ed. New York: McGraw Hill 1998: 1922-8.
2. th ed. Philadelphia: WB Saunders, 1999: 1533-83.
3. Hunninghake GW, Costabel U, Masayuki A, Baughman R, Cordier JF, duBois RM, et al: ATS, ERS, WASOG Statement on sarcoidosis. Amer J Respir Crit Care Med 1999; 160: 736-55.
4. Paramothayan NS, Jones PW: Corticosteroid therapy in pulmonary sarcoidosis. JAMA 2002; 287(10): 1301-7.
5. Izumi T: Are corticosteroids harmful to sarcoidosis-a conclusion drawn from a retrospective study on the chest radiographic prognosis of 185 asymptomatic patients with pulmonary sarcoidosis followed up for more than ten years, Sarcoidosis 1994; II(Supp 1); 119-22.
6. Gottlieb JE, Israel HL, Steiner RM, Triolo J, Patrick H: Outcome in sarcoidosis: the relationship of relapse to corticosteriod therapy. Chest 1997; 111: 623-31.
7. Reich JM: Mortality of intrathoracic sarcoidosis in referral vs. population-based settings: influence of stage, ethnicity, and corticosteroid therapy. Chest 2002; 121: 32-9.
8. Johnston RN: Pulmonary sarcoidosis after ten to twenty years. Scott Med J 1986; 31: 72-8.
9. Young RL, Harkleroad LE, Lordon RE, Weg JG: Pulmonary sarcoidosis: a prospective evaluation of glucocorticoid therapy. Ann Intern Med 1970; 73: 207-12.
10. Harkleroad LE, Young RL, Savage PJ, Jenkins DW, Lordon RE: Pulmonary sarcoidosis: Long-term follow-up of the effects of steroid therapy. Chest 1982; 82: 84-7.
11. Israel HL, Fouts DW, Beggs RA: A controlled trial of prednisone treatment of sarcoidosis. Amer Rev Resp Dis 1973; 107: 609-14.
12. Eule H, Weinecke A, Roth I: The possible influence of corticosteroid therapy on the natural course of sarcoidosis. Ann N Y Acad Sci 1986; 465: 695-701.
13. Mikami R, Hiraga Y, Iwai K, Kosuda T, Mochizuki H, Homma H, et al: A double-blind controlled trial on the effect of corticosteroid therapy in sarcoidosis. In: Iwai K, Hosoda Y, eds. Proceedings of the Sixth International Conference on Sarcoidosis (1972). Baltimore: University Park Press, 1974: 533-8.
14. Zaki MH, Lyons HA, Leilop L, Huang CT: Corticosteroid therapy in sarcoidosis: a five year, controlled follow-up study. NY State J Med 1987; 87: 496-9.
15. Hapke EJ, Meek JC: Steroid treatment in pulmonary sarcoidosis. In: Lavinskay L, Macholda F, eds. Fifth international conference on sarcoidosis (1969). Praha: Universita Karlova, 1971: 621-5.
16. Selroos O, Niemistö M, Riska N: A follow-up study of treated and untreated early sarcoidosis. In:. Iwai K, Hosoda Y, eds. Proceedings of the VI International Conference on Sarcoidosis, Tokyo 1972: Baltimore: University Park Press, 1974: 525-8.
17. Viskum K, Vestbo J: Vital Prognosis in intrathoracic sarcoidosis with special reference to pulmonary function and radiographic stage. Eur Respir J 1993; 6: 349-53.
18. Yamamoto M, Saito N, Taehibana T, Hiriga Y, Horikowa M, Osada H, et al: Effects of 18-month corticosteroid therapy on stage I and stage 11 sarcoidosis patients: a control trial. In: Chretien J, Marsac J, Saltiel J. eds. Sarcoidosis and other Granulomatous Disorders. Paris: Pergamon Press, 1981: 470-4.
19. Selroos O, Sellergren TL: Corticosteroid therapy of pulmonary sarcoidosis. Scand J Resp Dis 1979; 60: 215-21.
20. Gibson GJ, Prescott RJ, Muers MF, Middleton WG, Mitchell DN, Connolly CK, et al: British Thoracic Society sarcoidosis study: Effects of long term corticosteroid treatment. Thorax 1996; 51: 238-47.
21. duBois RM: Corticosteroids in sarcoidosis: friend or foe. Eu Respir J 1994; 7: 1203-9.
22. Sharma OP: Pulmonary sarcoidosis and corticosteroids. Amer Rev Respir Dis 993; 147: 1598-600.
23. Scadding JG: Prognosis of intrathoracic sarcoidosis in England: a review of 136 cases after five years of observation. Br Med J 1961; 4: 1165-72.
24. Hunninghake GW, Gilbert S, Pueringer R, Dayton C, Gloerchinger C, Helmers R, et al: Outcome of the treatment for sarcoidosis. Am J Respir Crit Care Med 1994; 149: 893-8.
25. Odlum CM, FitzGerald MX: Evidence that steroids alter the natural history of previously untreated progressive pulmonary sarcoidosis. Sarcoidosis 1986; 3: 40-6.
26. Pietinalho A, Tukiainen P, Haahtela T, Persson T, Selroos O: Early treatment of stage II sarcoidosis improves 5-year pulmonary function. Chest 2002; 121: 24-31.
27. Wyser CP, Emmcrcntia M, van Schalkwyk EM, Alheit B, Bardin PG, Joubert JR: Treatment of progressive pulmonary sarcoidosis with cyclosporin A: a randomized controlled trial. Am J Respir Crit Care Med 1997: 156: 1371-6.
28. Thomas PD, Hunninghake GW: State of the art: current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis 1987; 135: 747-60.
29. Munro CS, Mitchell DN, Poulter LW, Cole PJ: Immunological processes active in developing Kveim responses differ in normal and sarcoidosis subjects. Amer Rev Respir Dis 1986; 132(Supp): A244.
30. Reich JM: What is Sarcoidosis? Chest 2002; 124: 367-371.
31. Agostini C, Busso U, Semenzato G: Cells and molecules involved in the development of sarcoid granuloma. J Clin Immun 1998; 18(3): 184-92.
32. Milburn HJ, Poulter LW, Dihnec A, Cochrane GM, Kemeny DM: Corticosteroids restore the balance between locally produced Th1 and Th2 cytokines and immunoglobulin isotypes to normal in sarcoid lung. Clin Exp Immunol 1997; 108: 105-13.